Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2017.4887
Abstract: Results | We identified 401 interventional prostate cancer clinical trials with an overall survival end point from clinicaltrials .gov (Table). Overall, 47.9% (192) of these trials used sCr alone and/or required participants to have an… read more here.
Keywords: cells higher; treatment; association treatment; treatment hodgkin ... See more keywords
Subtotal splenectomy preserving the inferior splenic pole for the treatment of Hodgkin’s lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Surgery Case Reports"
DOI: 10.1016/j.ijscr.2017.04.015
Abstract: Highlights • First published case of subtotal splenectomy preserving the inferior splenic pole without the maintenance of the splenic vascular pedicle.• A very large spleen Hodgkin’s disease was successfully treated using a partial splenectomy.• A… read more here.
Keywords: splenectomy; treatment hodgkin; subtotal splenectomy; hodgkin lymphoma ... See more keywords
Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series
Sign Up to like & getrecommendations! Published in 2019 at "AntiCancer Research"
DOI: 10.21873/anticanres.13600
Abstract: Secondary malignancies are relatively common and clinically important phenomena following both chemotherapy and radiotherapy. The majority of these cases are acute leukemias, the occurrence of which have been thoroughly documented and studied. More rarely, chronic… read more here.
Keywords: hodgkin lymphoma; treatment; following treatment; treatment hodgkin ... See more keywords
Advances in the treatment of Hodgkin's lymphoma (Review)
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Oncology"
DOI: 10.3892/ijo.2023.5509
Abstract: Hodgkin's lymphoma (HL) is a unique B-cell lymphoproliferative malignancy that has a critical pathogenesis characterized by a sparse population of Hodgkin and Reed-Sternberg cells surrounded by numerous dysfunctional immune cells. Although systemic chemotherapy with or… read more here.
Keywords: advances treatment; hodgkin lymphoma; lymphoma; treatment hodgkin ... See more keywords